TPOXX is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Siga Technologies, Inc.. The primary component is Tecovirimat Monohydrate.
Product ID | 50072-200_638105d6-2895-4ab5-b1ef-3b5d95c196fa |
NDC | 50072-200 |
Product Type | Human Prescription Drug |
Proprietary Name | TPOXX |
Generic Name | Tecovirimat Monohydrate |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2018-08-31 |
Marketing Category | NDA / NDA |
Application Number | NDA208627 |
Labeler Name | SIGA Technologies, Inc. |
Substance Name | TECOVIRIMAT MONOHYDRATE |
Active Ingredient Strength | 200 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2018-08-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA208627 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-08-31 |
Ingredient | Strength |
---|---|
TECOVIRIMAT MONOHYDRATE | 200 mg/1 |
SPL SET ID: | fce826ab-4d6a-4139-a2ee-a304a913a253 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
50072-010 | TPOXX | tecovirimat monohydrate |
50072-200 | TPOXX | tecovirimat monohydrate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TPOXX 86409863 5046109 Live/Registered |
SIGA Technologies, Inc. 2014-09-30 |